Agios Pharma (AGIO) Tops Q3 EPS by $1

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of $16.22, $1.00 better than the analyst estimate of $15.22. Revenue for the quarter came in at $9 million versus the consensus estimate of $9.47 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• SpaceX files for 555.56M share IPO at $135/sh